The positive expression rates of GPX2 in lung adenocarcinoma tissues and paracancerous tissues were 60.0% and 15.5%, respectively, with statistically significant differences between groups P < 0.05 (Table 1).The comparison between groups was performed by the chi square test. This evidence concerns the gene GPX2 and lung adenocarcinoma.